ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CTEC Global X CleanTech ETF

7.28
0.02 (0.28%)
28 Nov 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Global X CleanTech ETF NASDAQ:CTEC NASDAQ Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.02 0.28% 7.28 6.70 7.86 7.41 7.24 7.41 17,094 01:00:00

Cholestech to Present at the Sidoti & Company Fifth Annual West Coast Emerging Growth Institutional Investor Forum

25/09/2006 9:48pm

PR Newswire (US)


Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart


From Nov 2019 to Nov 2024

Click Here for more Global X CleanTech ETF Charts.
HAYWARD, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Cholestech Corporation (NASDAQ:CTEC), a leading manufacturer of point of care testing devices, today announced that Jack F. Glenn, CFO, will present at the Sidoti & Company Fifth Annual West Coast Emerging Growth Institutional Investor Forum on Friday, September 29, 2006, at 11:00 a.m. Pacific Time in San Francisco, California. The presentation will include an overview of the company, current products, product pipeline and recent financial performance. About Cholestech Cholestech is committed to enabling people to lead longer, healthier and more active lives. Cholestech provides easy to use, accessible diagnostic tools and information to health care practitioners in over 35 countries around the world. Cholestech offers efficient and economic diagnostic testing for cholesterol and related lipids, blood glucose and glycemic control, and liver enzymes at the point of care. Health care providers can use the CLIA-waived Cholestech LDX(R) System and the GDX(TM) System(1), which is approved for prescription home use and hs-CRP for use in moderate complexity labs, to initiate and monitor the progress of patient therapy. By providing effective disease management solutions, Cholestech's goal is to be a leading provider of diagnostic tools and information for immediate risk assessment and therapeutic monitoring of heart disease and diabetes. Cholestech LDX(R) is a registered trademark and Cholestech GDX(TM) is a trademark of Cholestech Corporation. All other trademarks mentioned in this document are the property of their respective owners. For more information about Cholestech and its products visit us on the web at http://www.cholestech.com/. (1) GDX is 510(k) cleared for prescription home use and, accordingly, is CLIA waived. DATASOURCE: Cholestech Corporation CONTACT: Jack Glenn, Chief Financial Officer, Cholestech Corporation, +1-510-781-5065, or ; or Brendan Lahiff of Financial Dynamics, +1-415-439-4504, or , for Cholestech Corporation Web site: http://www.cholestech.com/

Copyright

1 Year Global X CleanTech ETF Chart

1 Year Global X CleanTech ETF Chart

1 Month Global X CleanTech ETF Chart

1 Month Global X CleanTech ETF Chart

Your Recent History

Delayed Upgrade Clock